Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-06

Clinical Trial Update: A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial comparing sertraline with paroxetine for panic disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paroxetine (Paroxetine hydrochloride)
  • Sertraline (Sertraline)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Panic Disorder | Phase 4 | Status: COMPLETED | Results posted: 2011-05-06